Skip to main content
European Commission logo
English English
CORDIS - EU research results
CORDIS
CORDIS Web 30th anniversary CORDIS Web 30th anniversary

Human on Chip : Microsensor unit and control algorithm integration for brain on a chip drug testing applications and development

Objective

"Cherry Biotech is an innovative French company which develops and commercializes microfluidic instruments for life sciences and healthcare. We position ourselves on a biological research market in which we are developing a range of tools dedicated to high resolution imaging. Other cellular environment control systems are also in test or development to support business growth. This technical base and the transversal skills held by the team has ideally positioned Cherry Biotech to carry out ambitious projects in the growing market of the Organs on a chip.
The design, development and implementation of microfluidic devices called ""Organ-on-a-Chip"" require the understanding and the integration of numerous components (technical, biological issues and constraints ...).
The candidate will take over from its genesis to the development of proof of concept the development of a microfluidic instrumentation platform to test therapeutic molecules on artificial organs (Brain) integrated within microfluidic chips. His challenge will be to integrate a complex technical environment (instrumentation, sensors, microfluidics) with important biological constraints.
"

Call for proposal

H2020-INNOSUP-2016-2017

See other projects for this call

Sub call

H2020-INNOSUP-02-2016

Coordinator

CHERRY BIOTECH
Net EU contribution
€ 81 875,00
Address
2EME ETAGE, HALLS A-B ET C14 RUE DE LA BEAUNE
93100 Montreuil
France

See on map

SME

The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.

Yes
Region
Ile-de-France Ile-de-France Seine-Saint-Denis
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
Links
Total cost
€ 81 875,00